Question

Difficulty: Very hardPulmonary and Critical Care

A 72-year-old man is evaluated in the intensive care unit for progressive lethargy and worsening shortness of breath over the past 12 hours. The patient was admitted 5 days ago for an acute exacerbation of heart failure. His medical history is significant for ischemic cardiomyopathy with a left ventricular ejection fraction of 25%25\% and severe chronic obstructive pulmonary disease (COPD) with a baseline FEV1\text{FEV}_1 of 35%35\% of predicted. Since admission, he has been treated with a continuous intravenous furosemide infusion, resulting in a net negative fluid balance of 8 liters and resolution of his peripheral edema. Vital signs currently show a temperature of 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure of 100/60 mm Hg100/60\text{ mm Hg}, heart rate of 105/min105/\text{min}, and respiratory rate of 10/min10/\text{min}. Oxygen saturation is 89%89\% on a 3 L/min3\text{ L/min} nasal cannula. Physical examination reveals a somnolent but arousable patient. The jugular venous pressure is estimated at 4 cm H2O4\text{ cm H}_2\text{O}. Pulmonary examination shows diminished breath sounds bilaterally with prolonged expiration and scattered end-expiratory wheezes, but no crackles are heard. Cardiovascular examination reveals distant heart sounds with a regular rate and rhythm.

Laboratory studies show the following:
TestResult
Sodium135 mEq/L135\text{ mEq/L}
Potassium2.9 mEq/L2.9\text{ mEq/L}
Chloride85 mEq/L85\text{ mEq/L}
Bicarbonate40 mEq/L40\text{ mEq/L}
Blood urea nitrogen55 mg/dL55\text{ mg/dL}
Creatinine1.8 mg/dL1.8\text{ mg/dL} (baseline 1.1 mg/dL1.1\text{ mg/dL})
Arterial blood gas analysis on 3 L/min3\text{ L/min} nasal cannula:
ParameterResult
pH7.527.52
pCO2\text{pCO}_250 mm Hg50\text{ mm Hg}
pO2\text{pO}_258 mm Hg58\text{ mm Hg}

Which of the following is the most appropriate next step in the management of this patient's respiratory status?

  1. Administer intravenous acetazolamide and potassium chlorideAnswer
  2. B
    Initiate noninvasive positive-pressure ventilation
  3. C
    Administer intravenous methylprednisolone and nebulized ipratropium-albuterol
  4. D
    Administer a rapid bolus of 0.9% normal saline
  5. E
    Administer intravenous levofloxacin and send sputum for culture

Answer

Administer intravenous acetazolamide and potassium chloride
This patient presents with a severe metabolic alkalosis (pH 7.527.52, bicarbonate 40 mEq/L40\text{ mEq/L}) secondary to aggressive loop diuretic therapy, known as contraction alkalosis. The elevated pCO2\text{pCO}_2 (50 mm Hg50\text{ mm Hg}) is the expected physiological respiratory compensation for metabolic alkalosis (Expected pCO2=40+0.7×(ΔHCO3−)=40+0.7×16≈51 mm Hg\text{Expected pCO}_2 = 40 + 0.7 \times (\Delta\text{HCO}_3^-) = 40 + 0.7 \times 16 \approx 51\text{ mm Hg}). The patient's hypoventilation (respiratory rate 10/min10/\text{min}) is a compensatory mechanism to retain CO2\text{CO}_2, which in turn causes secondary hypoxemia and lethargy. To improve his respiratory status, the underlying alkalosis must be corrected. Isotonic saline is the standard treatment for saline-responsive contraction alkalosis; however, it is strictly contraindicated in this patient with a left ventricular ejection fraction of 25%25\% who recently required 8 L8\text{ L} of diuresis, as it would precipitate flash pulmonary edema. Acetazolamide, a carbonic anhydrase inhibitor, promotes renal bicarbonate excretion to safely reverse the alkalosis, which will normalize his pH\text{pH}, restore normal respiratory drive, and resolve the hypoxemia. Concurrent potassium repletion is required because both the prior furosemide use and the new acetazolamide promote urinary potassium loss.

Step-by-Step Solution

1
Analyze the arterial blood gas values to identify the primary acid-base disorder.
The pH of 7.52 indicates alkalemia, and the elevated bicarbonate of 40 mEq/L confirms a primary metabolic alkalosis.
Establishing the primary disorder is essential to interpret the altered pCO2 and clinical presentation accurately.
2
Calculate the expected respiratory compensation for the metabolic alkalosis.
Expected pCO2 = 40 + 0.7 * (40 - 24) = 51.2 mm Hg. The patient's pCO2 of 50 mm Hg represents appropriate compensation.
This differentiates between an expected compensatory response and a superimposed primary respiratory disorder, such as an acute COPD exacerbation.
3
Correlate the acid-base derangement with the patient's clinical history and current symptoms.
Aggressive loop diuresis caused contraction alkalosis and severe hypokalemia. The patient is hypoventilating (RR 10/min) to retain CO2 as compensation, which leads to secondary hypoxemia and lethargy.
Understanding the physiologic mechanism allows for targeted, definitive therapy rather than symptomatic masking.
4
Select the most appropriate intervention that corrects the alkalosis without harming the patient.
Acetazolamide with potassium repletion is chosen. Isotonic saline is avoided.
While normal saline typically treats contraction alkalosis, it is absolutely contraindicated in this patient due to his recent severe acute decompensated heart failure and very low ejection fraction.

Key Concept

Patients with severe metabolic alkalosis compensate via alveolar hypoventilation, which can cause significant hypoxemia. In patients with concurrent severe heart failure where normal saline is contraindicated, acetazolamide is the treatment of choice to induce bicarbonate diuresis and reverse the alkalosis.
Estimated Time:2m 30s
Rate this question